Member Info for Timster

Obviously the FUD siren sounded when it dropped below 100 hanoihank

Maximum time it could have been running for is 4 weeks though so possibly on the second dose.

When there is no news they are getting on with it, just let them get on with it. Hopefully this escalation finds MTD if not there is one more and then a determination using the effective biological dose.

As Hurst🤖 predicted NY start 16/ 10/ 10/ 20/ then go for 100/

135 by Thursday when cohort news is expected+/ # wibble

Size buyers?

We'll be there shortly

100/ * 30/ 10/ 6/

Spot on yet again....

Boring this isn't it....

Bang on Hurst🤖

Hurst🤖 says cohort news this week.

He's never wrong....

2 shares bought, 48 shares bought, 3 shares bought, massive size.

I'm just humouring Hurst talking utter garbage again Harrogate

Size buyers been relentless this afternoon Hurstbot, like you say NY laughing, 3's, 48's, 2's

Good news Hurstbot 🤖 cohort update Monday, wouldn't want to be out over the weekend.

Bang on again Hurstbot 🤖

P.s why would there be cohort news next week it's only been running for 3 weeks. And there is only news when sujood says so.....

Spot on as always Hurstbot 🤖

I know it's slow while they continue to dose patients with levels of dox that would kill them if administered in its pure form but don't respond to these morons just report

They'll be back when the next payment is made on the loan.

The lth know what we have avacta know what they have, as was said earlier why would you enter a commercialisation phase of product lifecycle if it didn't do what it's supposed to do. It's just a matter of time now, it's a platform with AVA6000 being the first application of many in the pipeline.

Pre|CISION has the potential to completely change the landscape of toxic drug delivery.

Fantastic news for Avacta Hurstbot

Can we just agree that Derek and his mate wynbore are both morons with zero understanding of what they pertain to be invested in?

Thank goodness the expurt has arrived.

I'm sure the MHRA and FDA normally just ask the one question " does it work in mice" if the answer is yes they just go straight to the new standard of care.

It's just avacta faffing about with all this trial rubbish, what the hell is wrong with them?

Another quality post wynbore...... Really.... Top notch.....🤡🤡🤡🤡🤡🤡🤡

When you "invested" in a small biotech developing (amongst other things) a platform that can deliver existing (amongst other things) chemotherapy drugs directly to tumours, almost eliminating the plethora of awful side effects, top one being cardiotoxicity. Did you think, "that won't take long"? Or did you think, "wow, this sounds like an amazing opportunity for a long term investment"?

As the data of the phase 1a trial has emerged have you thought, "this isn't working" or have you thought "wow, therapeutic levels of dox delivered directly to the tumour with no cardiotoxicity and virtually no side effects, so much so a clinician couldn't even tell that a dose had been administered"?

Have you then thought, "I wish they'd plough on with phase 1b alongside 1a, which the CEO said could be a reckless waste of funds running at what could be a sub optimal dose" or have you thought " I'm glad they are doing this trial properly with a platform they are proving works highly efficiently "?

I don't think there has been any of the outrageous Uber ramping on here for a good while, just very good informational posts (amongst other things 🦭).

You could give up waiting and sell, or (as is your prerogative) keep moaning.

You don't think p1a data being published might be that point, the data from an extremely data rich trial? The point where AS said that's when commercialisation can start in earnest.